CYP 3.85% 25.0¢ cynata therapeutics limited

Ann: Investor Presentation, page-294

  1. 216 Posts.
    lightbulb Created with Sketch. 35
    I noticed you never got a reply from the hit and run Goon Squad team member Lopez to back up patents cliam. Just the usual cheap rabbiting out of fear.

    A good read here on patents below and how 70% of recent challenges have been successful.
    Much easier and cheaper to challenge broad brush stem cell patents from early days. (which Mesoblast holds many)

    https://www.sciencedirect.com/science/article/pii/S1934590915001733

    The Mesoblast patent rampers may like to ask one simple question of themselves. How many companies in 20 years have licensed their IP?
    Most of them are expiring quickly and are quite useless nowadays hence why no interest.
    Takeda's product ended up a failure due to terrible manufacturing requirements. (hint)
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.